MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$191,086K
Provision for income taxes
-$93K
Loss before
provision for income taxes
-$191,179K
Interest income
$9,251K
Ipsen Pharma SAS
$56,357K
Astellas Pharma Inc
Astellas
$45,423K
Vaxcyte Inc
$600K
Tasly
Biopharmaceuticals Co Ltd
$104K
Loss from operations
-$158,367K
Non-cash interest
expense related to the...
$38,208K
Revenue
$102,484K
Interest and other income
(expense), net
-$3,855K
Total operating
expenses
$260,851K
Research and development
$166,417K
Restructuring and related
costs
$53,415K
General and
administrative
$41,019K
Back
Back
Income Statement
source: myfinsight.com
SUTRO BIOPHARMA, INC. (STRO)
SUTRO BIOPHARMA, INC. (STRO)